Novartis share price logo

Novartis

NYSE: NVS

Mega Cap

$142.57

-3.14

(-2.15%)

as on

Novartis Stock Performance

as on October 1, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $142.66
    $145.50
    downward going graph

    -0.06%

    Downside

    2.06%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $121.57
    $170.46
    downward going graph

    14.73%

    Downside

    19.56%

    Upside

    downward going graph

Novartis share price movements today

Previous Close
$145.71
Open
$145.40
Volume
2.2M
Market Cap
$265.4B
Dividend Yield
3.25%
Day's Low - High
$142.66 - $145.50
52 Week Low - High
$121.57 - $170.46

Novartis Historical Returns

1 Month Return
-11.58 %
3 Month Return
-7.51 %
1 Year Return
+ 8.24 %
3 Year Return
+ 39.97 %
5 Year Return
+ 73.84 %

Novartis Stock Fundamentals & Key Indicators

Check Novartis market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$265.4B

EPS (TTM)

6.66

Dividend Yield

3.25%

Quarterly Earnings Growth YOY

-0.17%

PE Ratio (TTM)

22.06

Industry PE ratio

27.11

PEG Ratio

-4.91

EBITDA

22.3B

Revenue (TTM)

55.6B

Profit Margin

74.29%

Return On Equity TTM

29.64%

Novartis vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Novartis with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Neutral$265.4B73.84%22.0674.29%3.25%
StrongBuy$1.1T403.98%39.2783.40%0.56%
StrongBuy$465.3B139.79%74.3371.48%2.59%
StrongBuy$644.8B64.98%30.8167.91%1.97%
Buy$368.3B78.51%116.6375.38%2.28%

Stock Returns calculator for Novartis Stock including INR - Dollar returns

The Novartis stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Novartis investment value today

Current value as on today

₹1,16,752

Returns

₹16,752

(+16.75%)

Returns from Novartis Stock

₹8,237 (+8.24%)

Dollar Impact

₹8,515 (+8.51%)

Analyst Recommendation on Novartis Stock

Based on 4 analysts

HOLD

25.00%

Buy

75.00%

Hold

0.00%

Sell

Based on 4 analysts, 75% of analysts recommend a 'HOLD' rating for Novartis. Average target price of $156.29

Novartis Share Price Target

Get share price movements and forecasts by analysts on Novartis.

What analysts predicted

8.78%UPSIDE

Target Price

$156.29

Current Price

$142.57

Analyzed by

4 Analysts

High

$180

Target

$156.29

Low

$136

Novartis target price $156.29, a slight upside of 8.78% compared to current price of $142.57. According to 4 analysts rating.

Indian Investors' Interest in Novartis Stock

Investment in Novartis Shares on INDmoney has grown by 275.72% in the last 30 days, indicating increased investment activity.

Time period: to

Change:275.72% versus previous 30 day period

Search interest for Novartis Stock has increased by 140% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:140% versus previous 30 day period

Novartis Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
12,120
12,872
13,172
13,558
13,620
14,836
14,358
13,334
13,524
14,417
Gross Profit
9,024
9,699
9,938
10,234
10,393
11,514
10,819
9,793
10,065
10,737
Operating Income
3,373
4,014
3,627
3,530
4,663
4,864
4,501
3,520
4,235
4,735
EBITDA
4,664
5,249
5,614
5,188
5,831
6,076
5,841
5,072
5,410
5,936
Interest Expense
219
245
266
273
270
293
281
303
343
462
Depreciation
1,314
1,162
1,965
1,628
1,154
1,256
1,364
1,550
1,228
1,200
Income Before Tax
3,129
3,841
3,385
3,285
4,407
4,531
4,196
3,217
3,839
4,271
Income Tax Expense
441
595
200
465
798
507
266
813
683
1,012
Net Income
2,688
3,246
3,189
2,818
3,606
4,041
3,928
2,408
3,156
3,266
Net Profit Margin
74.46%
75.35%
75.45%
75.48%
76.31%
77.61%
75.35%
73.44%
74.42%
74.47%

Novartis Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
43,404
46,099
48,677
49,898
43,974
43,461
46,660
51,722
54,811
Gross Profit
29,771
31,589
34,252
34,777
32,239
31,879
34,188
38,895
41,121
Operating Income
8,702
8,403
9,086
10,152
10,056
7,946
9,769
14,544
17,073
EBITDA
14,588
20,238
15,616
17,211
30,914
14,682
18,255
20,715
22,987
Interest Expense
802
973
902
921
905
834
876
1,036
1,187
Depreciation
4,736
5,211
5,826
6,464
5,597
6,705
8,277
6,069
5,352
Income Before Tax
9,102
14,095
8,940
9,878
24,530
7,177
9,123
13,640
16,435
Income Tax Expense
1,603
1,295
1,793
1,807
1,625
1,128
551
1,701
2,397
Net Income
7,703
12,611
11,732
8,072
24,021
6,955
14,850
11,941
14,055
Net Profit Margin
68.59%
68.52%
70.37%
69.70%
73.31%
73.35%
73.27%
75.20%
75.02%

Novartis Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
2,688
3,246
3,189
2,818
3,606
4,024
3,930
2,408
3,156
3,266
Operating Cash Flow
2,265
4,875
6,286
4,193
3,645
6,664
6,571
2,253
3,676
5,888
Investing Cash Flow
-899
-3,207
-374
-3,033
330
-2,243
-860
-2,111
-11,736
-3,090
Financing Cash Flow
-5,164
-3,200
-382
-2,996
-8,548
-5,213
-2,789
1,713
3,579
-2,030
Change in Cash
-3,924
-1,566
5,706
-2,150
-4,393
-410
2,900
1,879
-4,558
739

Novartis Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
7,703
12,614
7,147
8,071
22,905
6,049
8,572
11,939
14,055
Operating Cash Flow
12,621
14,272
13,625
13,650
15,071
14,236
14,458
17,619
19,242
Investing Cash Flow
-3,119
-5,591
-2,226
-13,182
4,208
1,468
5,596
-7,513
-4,901
Financing Cash Flow
-7,733
-4,244
-13,627
-2,208
-16,264
-20,562
-14,278
-11,742
-14,943
Change in Cash
1,853
4,411
-2,159
-1,454
2,749
-4,890
5,876
-1,934
-23

Global Institutional Holdings in Novartis

Check out the Institutions with significant holdings in Novartis.

Funds
Holdings
Ken Fisher
0.76%
Theofanis Kolokotrones
0.32%
VANGUARD CHESTER FUNDS
0.26%
Dodge & Cox Funds
0.25%
DFA INVESTMENT DIMENSIONS GROUP INC
0.25%

Novartis News & Key Events

  • img

    Today's Timeline - 14 September

    Mon, 10:45 AM

    -

    Novartis shares fell after late-stage failures for del-desiran and cholesterol candidate, leading to analyst downgrades.

Insights on Novartis

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Novartis AG has shown consistent growth in its net profit over the last three quarters. The net profit increased from $2.40 billion to $3.26 billion, reflecting an average quarterly increase of 13.5%. This trend indicates strong financial performance for the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Novartis AG has shown a positive trend in its revenue over the last three quarters. The revenue increased from $13.33 billion to $14.41 billion, averaging a growth of 3.8% each quarter.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Merck & Co., Inc. has given 61.2% return, outperforming this stock by 53.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Eli Lilly & Co. has given 41.1% return, outperforming this stock by 1.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, NVS stock has moved down by -11.6%

About Novartis

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
OrganisationNovartis
HeadquartersLichtstrasse 35, Basel, BS, 4056, CH
IndustryDrug Manufacturers - General
CEOVasant Narasimhan

Key Management of Novartis

Name

Title

Mr. Victor Bulto

President of US

Dr. Patrick Horber M.D.

President of International

Mr. Mukul Mehta

Chief Financial Officer

Ms. Sloan Simpson

Global Head of Investor Relations

Mr. Evan Beckman

Global Head of Translational Medicine at Novartis Institute for BioMedical Research

Dr. Vasant Narasimhan M.D.

Chief Executive Officer

Dr. Steffen Lang Ph.D.

President of Operations

Paul Penepent

Head of Group Financial Reporting and Accounting

Ms. Karen L. Hale

Chief Legal & Compliance Officer

Dr. Robert Kowalski Pharm.D.

Chief People & Organization Officer

FAQs

What is Novartis share price today?

Novartis share price today is $142.57 as on at the close of the market. Novartis share today touched a day high of $145.50 and a low of $142.66.

What is the 52 week high and 52 week low for Novartis share?

Novartis share touched a 52 week high of $170.46 on and a 52 week low of $121.57 on . Novartis stock price today i.e. is closed at $142.57,which is 16.36% down from its 52 week high and 17.27% up from its 52 week low.

What is Novartis's market capitalisation today?

Novartis market capitalisation is $0.27T as on .

How to invest in Novartis Stock (NVS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Novartis on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Novartis Stock (NVS) from India?

Indian investors can start investing in Novartis (NVS) shares with as little as ₹95.83000183105469 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.30 in Novartis stock (as per the Rupee-Dollar exchange rate as on ). Based on Novartis share’s latest price of $142.57 as on October 1, 2026 at 8:45 am IST, you will get 0.0701 shares of Novartis. Learn more about fractional shares .

What are the returns that Novartis has given to Indian investors in the last 5 years?

Novartis stock has given 73.84% share price returns and 29.42% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?